WebApr 11, 2024 · Freeline Therapeutics' mailing address is STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD STEVENAGE, HERTFORDSHIRE X0, SG12FX. … WebMar 28, 2024 · About Freeline Therapeutics ... Media and Investor Contact: Naomi Aoki [email protected] Senior Vice President, Head of Investor Relations & …
AviadoBio
WebStevenage Bioscience Catalyst, Gunnels Wood Road, Hertfordshire ... +44 1438 906870. [email protected]. Web Site. N/A. Milestones Related Companies Press Releases Funding Offices Competitors Links Investments Edit. ... Freeline Therapeutics Recommended Market Profiles (6) Telemedicine. 10,000 or More employees. WebDescription. Freeline Therapeutics Holdings PLC is a clinical-stage biotechnology company developing transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its lead product candidates are FLT180a for the treatment of hemophilia B, FLT190 for the treatment ... temp 03031
Freeline Therapeutics : Appoints Henning R. Stennicke, PhD, As …
WebFreeline 8,234 followers on LinkedIn. Driven to be ‘life-changers’, a vision inspired by people with chronic diseases and made possible by our gene technology Freeline is a clinical-stage biotechnology company developing AAV gene therapies. We are dedicated to improving patient lives through innovative, one-time treatments for chronic debilitating … WebChris Hollowood. Chris is the Chief Executive Officer of Syncona Investment Management Ltd. He has been instrumental in the foundation and development of Syncona's gene … WebApr 12, 2024 · April 12, 2024 - 8:00 am. LONDON, April 12, 2024 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that its Chief Executive Officer Michael Parini will present at the 22 nd Annual Needham Virtual Healthcare Conference being held on April 17-20, 2024. The presentation will take place … temp 02910